Jonathan R. Zimmerman

Capital Markets & Public Companies

• Extensive experience representing issuers and investment banks in billions of dollars of securities offerings, including IPOs, secondary offerings, registered direct offerings, PIPEs, Rule 144A, and foreign offerings.
• Advisor to leading public companies across multiple sectors including:
  
  • Life Sciences: Celcuity, Mineralys Therapeutics, DiaMedica Therapeutics, and Tactile Medical
  • Technology & Innovation: SPS Commerce, Spire Global, and Aeluma
  • Consumer & Industrial: Mama's Creations, Arena Group, and FGI Industries
• Skilled in SEC reporting, compliance, corporate governance, resales of restricted securities, and equity compensation.
• Skilled in capital markets transactions including going-private deals, issuer tender offers for debt and equity, and security purchase programs including accelerated stock repurchases.
• Recognized as a market leader by Chambers for his deep experience in complex micro-cap transactions, where regulatory challenges and liquidity hurdles are unique.

Mergers & Acquisitions

• Proven track record in high-value M&A, including multibillion-dollar exits for public companies and serial buy-side transactions for acquisitive clients.
• Represents investment banks as financial advisors in M&A, providing counsel on deal structuring, fairness opinions, and proxy disclosures.
• Known for strategic, commercially minded advice aligned with client objectives.

Venture Capital & Emerging Companies

• Represents emerging companies, venture capital, hedge funds, private equity, and corporate venture funds in private placements and strategic investments.
• Acts as outside general counsel to growth companies, offering practical guidance on governance through all stages of development.
• Jonathan's advice is informed by his background as a former independent record label owner. He understands the "founder's grind" and the operational realities of scaling a business, allowing him to deliver counsel that is as entrepreneurial as it is legal.

Why Select Jonathan?

• Consistently ranked among top lawyers in capital markets and M&A by Chambers USA, LMG Life Sciences, and Best Lawyers^®.
• Frictionless execution: Known for cutting through "legal noise" to keep deals on track, Jonathan prioritizes speed-to-market without compromising regulatory integrity.
• Recognized for delivering business-first, actionable solutions and exceptional client service. Deep commitment to responsiveness and value creation at every stage of the transaction.
• As a "Leading Life Sciences Lawyer," Jonathan has a particular depth in medtech, biotech/pharma, and health care, guiding companies like Celcuity and Tactile Medical through the unique intersection of FDA milestones and capital raises, as well as companies like CoLucid Pharmaceuticals and Endocyte through eight-figure exits.

What Clients Have Said

• "Jonathan Zimmerman is widely held to be a leader on the Minnesota capital markets Bar, with experience spanning debt and equity deals, [and] micro-cap transactions." — Capital Markets: Debt & Equity respondent, Chambers USA
• "Jonathan is an excellent securities [attorney] with strong communication and client service skills. He is practical and takes the time to walk us through any issues." — Corporate/M&A respondent, Chambers USA

Personal Interests

Jonathan is an avid world traveler and former triathlete. He also brings the entrepreneurial edge. As a former independent record label owner, Jonathan views transactions through the lens of a founder. He brings a rare "operator's empathy" to his practice, allowing him to bridge the gap between complex legal frameworks and the creative needs of growth-oriented companies.